These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 1560559

  • 1. New RGD analogue inhibits human platelet adhesion and aggregation and eliminates platelet deposition on canine vascular grafts.
    Rubin BG, McGraw DJ, Sicard GA, Santoro SA.
    J Vasc Surg; 1992 Apr; 15(4):683-91; discussion 691-2. PubMed ID: 1560559
    [Abstract] [Full Text] [Related]

  • 2. Antiplatelet and antithrombotic effects of platelet glycoprotein IIb/IIIa (GPIIb/IIIa) inhibition by arginine-glycine-aspartic acid-serine (RGDS) and arginine-glycine-aspartic acid (RGD) (O-me)Y (SC-46749).
    Nicholson NS, Panzer-Knodle SG, Salyers AK, Taite BB, King LW, Miyano M, Gorczynski RJ, Williams MH, Zupec ME, Tjoeng FS.
    J Pharmacol Exp Ther; 1991 Mar; 256(3):876-82. PubMed ID: 2005585
    [Abstract] [Full Text] [Related]

  • 3. Antithrombotic effects of MK-0852, a platelet fibrinogen receptor antagonist, in canine models of thrombosis.
    Ramjit DR, Lynch JJ, Sitko GR, Mellott MJ, Holahan MA, Stabilito II, Stranieri MT, Zhang G, Lynch RJ, Manno PD.
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1501-11. PubMed ID: 8371153
    [Abstract] [Full Text] [Related]

  • 4. The fibrinogen gamma chain dodecapeptide inhibits agonist-induced aggregation of rabbit platelets and fibrinogen binding to rabbit glycoprotein IIb-IIIa.
    Rand ML, Packham MA, Taylor DM, Yeo EL, Gemmell CH, Patil S, Lam SC.
    Thromb Haemost; 1999 Dec; 82(6):1680-6. PubMed ID: 10613655
    [Abstract] [Full Text] [Related]

  • 5. The in-vitro effect of tirofiban, glycoprotein IIb/IIIa antagonist, on various responses of porcine blood platelets.
    Ciborowski M, Tomasiak M, Rusak T, Winnicka K, Dobrzycki S.
    Blood Coagul Fibrinolysis; 2008 Sep; 19(6):557-67. PubMed ID: 18685439
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. SC-49992, a mimetic of the peptide arginine-glycine-aspartic acid-phenylalanine that blocks platelet aggregation, enhances recombinant tissue plasminogen activator-induced thrombolysis and prevents reocclusion in a canine model of coronary artery thrombosis.
    Feigen LP, Nicholson NS, King LW, Campion JG, Tjoeng FS, Panzer-Knodle SG.
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1191-7. PubMed ID: 8263779
    [Abstract] [Full Text] [Related]

  • 12. Platelet aggregation and fibrinogen binding in human, rhesus monkey, guinea-pig, hamster and rat blood: activation by ADP and a thrombin receptor peptide and inhibition by glycoprotein IIb/IIIa antagonists.
    Cook NS, Zerwes HG, Tapparelli C, Powling M, Singh J, Metternich R, Hagenbach A.
    Thromb Haemost; 1993 Sep 01; 70(3):531-9. PubMed ID: 8259560
    [Abstract] [Full Text] [Related]

  • 13. Inhibitory effect of a novel orally active GP IIb/IIIa inhibitor, SC-54684A on intimal thickening in the guinea pig femoral artery.
    Umemura K, Nishiyama H, Kikuchi S, Kondo K, Nakashima M.
    Thromb Haemost; 1996 Nov 01; 76(5):799-806. PubMed ID: 8950793
    [Abstract] [Full Text] [Related]

  • 14. Crovidisin, a collagen-binding protein isolated from snake venom of Crotalus viridis, prevents platelet-collagen interaction.
    Liu CZ, Huang TF.
    Arch Biochem Biophys; 1997 Jan 15; 337(2):291-9. PubMed ID: 9016825
    [Abstract] [Full Text] [Related]

  • 15. The association of in vitro arachidonic acid responsiveness and plasma thromboxane levels with early platelet deposition on the luminal surface of small-diameter grafts.
    Freeman MB, Sicard GA, Valentin LI, Neuberger S, Mangino MJ, Anderson CB.
    J Vasc Surg; 1988 Apr 15; 7(4):554-61. PubMed ID: 3127601
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of human platelet aggregation by GR91669, a prototype fibrinogen receptor antagonist.
    Foster MR, Hornby EJ, Brown S, Hann M, Kitchin J, Pike N, Ward P.
    Thromb Res; 1994 Aug 01; 75(3):269-84. PubMed ID: 7992238
    [Abstract] [Full Text] [Related]

  • 17. Triflavin, an antiplatelet Arg-Gly-Asp-containing peptide, is a specific antagonist of platelet membrane glycoprotein IIb-IIIa complex.
    Huang TF, Sheu JR, Teng CM, Chen SW, Liu CS.
    J Biochem; 1991 Feb 01; 109(2):328-34. PubMed ID: 1864844
    [Abstract] [Full Text] [Related]

  • 18. The effects of two synthetic glycoprotein IIb/IIIa antagonists, Ro 43-8857 and L-700,462, on platelet aggregation and bleeding in guinea-pigs and dogs: evidence that Ro 43-8857 is orally active.
    Cook NS, Bruttger O, Pally C, Hagenbach A.
    Thromb Haemost; 1993 Nov 15; 70(5):838-47. PubMed ID: 8128443
    [Abstract] [Full Text] [Related]

  • 19. Identification of low molecular weight GP IIb/IIIa antagonists that bind preferentially to activated platelets.
    Bednar RA, Gaul SL, Hamill TG, Egbertson MS, Shafer JA, Hartman GD, Gould RJ, Bednar B.
    J Pharmacol Exp Ther; 1998 Jun 15; 285(3):1317-26. PubMed ID: 9618439
    [Abstract] [Full Text] [Related]

  • 20. Functional relevance of the expression of ligand-induced binding sites in the response to platelet GP IIb/IIIa antagonists in vivo.
    Murphy NP, Pratico D, Fitzgerald DJ.
    J Pharmacol Exp Ther; 1998 Aug 15; 286(2):945-51. PubMed ID: 9694954
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.